…
Oakridge International Limited, together with its subsidiaries, engages in the sale of professional healthcare technology equipment and solutions to healthcare facilities. The company develops and distributes a range of nurse call hardware and software solutions for use in multiple healthcare sectors, including hospitals, aged care, disability care, and supported independent living facilities. It is also engaged in the development of Internet of Things technology activities. The company was formerly known as Xped Limited and changed its name to Oakridge International Limited in April 2021. Oakridge International Limited is based in Adelaide, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Oakridge International Ltd is limited, and the company's core operations and long-term strategy are not widely disclosed. If the company pursues expansion, investors may find exposure to international markets and potential scale-up opportunities attractive, though outcomes depend on execution.
Principal investment risks include opaque disclosure and low market liquidity, execution and financing risk for any growth initiatives, and regulatory or geopolitical exposure in jurisdictions where the company may operate.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -0.24M | -0.21M | -0.76M | -0.27M | -0.66M |
| Net income | 0.11M | -0.13M | -0.76M | -0.12M | -0.53M |
| Selling general administrative | - | 1.02M | 0.93M | 0.39M | 0.48M |
| Selling and marketing expenses | - | 0.05M | 0.03M | 0.01M | 0.02M |
| Gross profit | 0.63M | 1.12M | 0.48M | 0.09M | -0.25M |
| Reconciled depreciation | - | 0.11M | 0.11M | 0.03M | 0.03M |
| Ebit | -0.22M | -0.20M | -0.90M | -0.51M | -0.65M |
| Ebitda | -0.10M | -0.09M | -0.79M | -0.47M | -0.61M |
| Depreciation and amortization | 0.12M | 0.11M | 0.11M | 0.03M | 0.04M |
| Operating income | -0.22M | -0.65M | -1.01M | -0.51M | -0.65M |
| Other operating expenses | 3.32M | 2.88M | 1.82M | 1.60M | 1.15M |
| Interest expense | 0.00M | 0.01M | 0.04M | 0.03M | 0.03M |
| Tax provision | - | -0.08M | 0.00M | 0.00M | 0.00M |
| Interest income | - | 0.00M | 0.01M | 0.01M | 0.01M |
| Net interest income | - | -0.01M | -0.04M | -0.01M | -0.02M |
| Extraordinary items | - | 0.00M | - | 0.00M | -0.00M |
| Income tax expense | -0.35M | -0.08M | -0.18M | -0.15M | -0.13M |
| Total revenue | 3.09M | 2.23M | 0.81M | 1.10M | 0.50M |
| Total operating expenses | 0.85M | 1.77M | 0.75M | 0.60M | 0.40M |
| Cost of revenue | 2.46M | 1.11M | 0.33M | 1.01M | 0.75M |
| Total other income expense net | -0.02M | 0.44M | 0.25M | 0.24M | -0.01M |
| Discontinued operations | - | - | - | - | -0.00M |
| Net income from continuing ops | - | -0.13M | -0.76M | -0.12M | -0.53M |
| Net income applicable to common shares | - | -0.13M | -0.76M | -0.12M | -0.53M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 2.12M | 1.61M | 1.81M | 1.99M | 2.16M |
| Intangible assets | - | - | - | 0.00M | 0.00M |
| Other current assets | 0.14M | - | 0.01M | 0.01M | 0.01M |
| Total liab | 0.76M | 0.70M | 0.78M | 0.76M | 0.81M |
| Total stockholder equity | 1.36M | 0.90M | 1.03M | 1.23M | 1.35M |
| Other current liab | 0.30M | - | 0.29M | 0.26M | 0.72M |
| Common stock | 29.68M | - | 29.33M | 28.80M | 28.80M |
| Capital stock | - | 29.33M | - | 28.80M | 28.80M |
| Retained earnings | -28.35M | -28.46M | -28.33M | -27.57M | -27.45M |
| Other liab | - | - | - | 0.02M | 0.01M |
| Other assets | - | - | 0.00M | - | - |
| Cash | 0.64M | 0.47M | 0.96M | 1.09M | 1.73M |
| Total current liabilities | 0.74M | 0.63M | 0.59M | 0.55M | 0.80M |
| Current deferred revenue | 0.06M | - | 0.04M | 0.02M | -0.28M |
| Net debt | -0.54M | - | -0.66M | -0.80M | -1.45M |
| Short term debt | 0.10M | - | 0.13M | 0.10M | 0.28M |
| Short long term debt | - | 0.03M | - | 0.03M | 0.28M |
| Short long term debt total | 0.10M | - | 0.30M | 0.29M | 0.28M |
| Other stockholder equity | - | - | - | -1.23M | -1.35M |
| Property plant equipment | - | - | - | 0.29M | 0.02M |
| Total current assets | 1.92M | 1.38M | 1.51M | 1.69M | 2.13M |
| Net tangible assets | - | - | - | 1.23M | 1.35M |
| Short term investments | 0.06M | 0.06M | 0.06M | 0.05M | 0.10M |
| Net receivables | 0.28M | 0.14M | 0.17M | 0.10M | 0.22M |
| Long term debt | - | - | - | - | 0.00M |
| Inventory | 0.80M | 0.38M | 0.31M | 0.44M | 0.08M |
| Accounts payable | 0.29M | 0.16M | 0.12M | 0.17M | 0.08M |
| Accumulated other comprehensive income | 0.03M | - | 0.03M | - | - |
| Non currrent assets other | - | - | -0.00M | -0.00M | -0.00M |
| Non current assets total | 0.20M | 0.22M | 0.30M | 0.29M | 0.02M |
| Capital lease obligations | - | 0.17M | - | 0.26M | - |
| Long term debt total | - | - | - | 0.19M | 0.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.04M | -0.02M | 0.02M | -0.00M |
| Change to liabilities | - | - | - | 0.13M | -0.04M |
| Total cashflows from investing activities | -0.10M | -0.04M | -0.02M | 0.02M | -0.00M |
| Net borrowings | - | - | - | -0.24M | -0.02M |
| Total cash from financing activities | 0.14M | -0.10M | 0.42M | -0.24M | -0.02M |
| Change to operating activities | - | - | - | 0.02M | -0.01M |
| Net income | 0.11M | -0.13M | -0.76M | -0.12M | -0.53M |
| Change in cash | 0.17M | -0.49M | -0.13M | -0.63M | -0.65M |
| Begin period cash flow | 0.47M | 0.96M | 1.09M | 1.73M | 2.38M |
| End period cash flow | 0.64M | 0.47M | 0.96M | 1.09M | 1.73M |
| Total cash from operating activities | 0.13M | -0.36M | -0.53M | -0.41M | -0.63M |
| Issuance of capital stock | - | - | 0.50M | - | - |
| Depreciation | 0.12M | 0.11M | 0.11M | 0.03M | 0.04M |
| Other cashflows from investing activities | - | 0.00M | 0.00M | 0.05M | 0.00M |
| Change to inventory | -0.41M | 0.17M | 0.14M | -0.26M | 0.04M |
| Change to account receivables | -0.15M | 0.03M | -0.07M | 0.12M | -0.02M |
| Sale purchase of stock | - | 0.00M | 0.50M | - | 0.00M |
| Other cashflows from financing activities | -0.11M | - | -0.08M | -0.02M | -0.00M |
| Change to netincome | - | - | - | -0.34M | -0.09M |
| Capital expenditures | 0.10M | 0.04M | 0.02M | 0.03M | 0.00M |
| Change in working capital | -0.21M | -0.11M | 0.08M | 0.01M | -0.04M |
| Stock based compensation | - | - | 0.06M | - | - |
| Other non cash items | 0.10M | -0.24M | -0.02M | -0.34M | -0.11M |
| Free cash flow | 0.03M | -0.40M | -0.55M | -0.44M | -0.63M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| OAK Oakridge International Ltd |
- -% |
0.06 | - | - | 0.74 | 1.88 | 0.63 | 8.25 |
| PME Pro Medicus Ltd |
-4.52 2.18% |
202.79 | 81.98 | 106.38 | 83.13 | 43.70 | 74.38 | 95.34 |
| 4DX 4DMEDICAL Ltd |
-0.06 2.53% |
2.31 | - | - | 205.57 | 8.53 | 170.03 | -7.29 |
| CGS Cogstate Ltd |
0.12 3.30% |
3.76 | 33.80 | 27.86 | 9.59 | 6.95 | 6.35 | 19.27 |
| AYA ARTRYA Ltd |
-0.14 3.91% |
3.44 | - | - | 20505.14 | 7.00 | 16927.51 | 0.33 |
Oakridge International Limited, together with its subsidiaries, engages in the sale of professional healthcare technology equipment and solutions to healthcare facilities. The company develops and distributes a range of nurse call hardware and software solutions for use in multiple healthcare sectors, including hospitals, aged care, disability care, and supported independent living facilities. It is also engaged in the development of Internet of Things technology activities. The company was formerly known as Xped Limited and changed its name to Oakridge International Limited in April 2021. Oakridge International Limited is based in Adelaide, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Con Unerkov | Exec. Chairman, CEO & Interim CFO | NA |
| Mr. John Schultz | Founder & Head of Engineering | 1965 |
| Mr. Christopher Wood | Founder & CTO | 1962 |
| Ms. Julie Edwards | Company Sec. | NA |
| Mr. Michael Raymond Clarke | Consultant | 1976 |
| Dr. Wenjun Sheng Ph.D. | Consultant | 1975 |
| Mr. Con Unerkov | Executive Chairman, CEO & Interim CFO | 1969 |
| Ms. Julie Edwards | Company Secretary | NA |
| Mr. Con Unerkov | Executive Chairman, CEO & Interim CFO | 1969 |
| Ms. Julie Edwards | Company Secretary | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.